Home » Newsletters » BioWorld

BioWorld

June 27, 1997

View Archived Issues

Mutant Gene Product Found In Early Onset Parkinson's Disease Defines Inheritance

Maxim Pharmaceutical's Melanoma Product Moves Into Phase III

Pasteur Merieux Connaught Invests C$350 Million In Canada-Wide Cancer Vaccine Pr

CuraGen Takes Genomics Know-How To The Table For $25M Deal -- In Ag Research

Arris Pharmaceutical's Asthma Drug Works In Phase IIa Trials

Other News to Note

ViroPharma Seeks To Raise $30M In Public Offering

FDA Panel Recommends Neurex's Corlopam For High Blood Pressure

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.